LIFESTANCE HEALTH GROUP INC (LFST) Stock Earnings & Estimates
USA - NASDAQ:LFST - US53228F1012 - Common Stock
6.4 USD
+0.09 (+1.43%)
6.4 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 859.5M 28.76% | 1.056B 22.82% | 1.251B 18.50% | 1.443B 15.35% | 1.647B 14.14% | 1.896B 15.12% | 2.015B 6.28% | |
| EBITDA YoY % growth | -136.9M 40.23% | -106.911M 21.91% | 39.509M 136.96% | 147.55M 273.46% | 182.32M 23.56% | 234.7M 28.73% | N/A | |
| EBIT YoY % growth | -206.1M 27.22% | -187.348M 9.10% | -31.441M 83.22% | 3.421M 110.88% | 40.275M 1,077.29% | 92.554M 129.81% | 64.469M -30.34% | |
| Operating Margin | -23.98% | -17.75% | -2.51% | 0.24% | 2.45% | 4.88% | 3.20% | |
| EPS YoY % growth | -0.61 20.26% | -0.51 16.39% | -0.16 68.63% | -0.03 80.88% | 0.04 233.33% | 0.19 356.25% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 100.00% | 0.00 91.48% | 0.01 | 0.01 227.50% | 0.02 | 0.02 1,297.60% | 0.01 49.93% | 0.01 -20.00% | 0.02 25.00% | 0.03 50.00% |
| Revenue Q2Q % growth | 362.72M 16.34% | 386.47M 18.74% | 389.76M 17.06% | 402.2M 16.47% | 417.61M 14.79% | 442.04M 14.38% | 440.86M 13.11% | 468.66M 16.52% | 485.85M 16.34% | 503.7M 13.95% |
| EBITDA Q2Q % growth | 40.342M -28.38% | 41.248M -42.72% | 41.241M 168.50% | 43.251M 74.31% | 44.498M 10.30% | 48.404M 17.35% | 47.649M 15.54% | 54.988M 27.14% | 53.647M 20.56% | 59.099M 22.10% |
| EBIT Q2Q % growth | 358.02K 661.74% | 3.429M 223.80% | 3.848M 139.90% | 8.301M 381.39% | 7.707M 2,052.67% | 9.012M 162.82% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.00 100.00% | -0.01 | 0.01 | 100.00% |
| Q2 2025 Q2Q % growth | -0.01 83.33% | -0.03 | 0.02 | 67.32% |
| Q1 2025 Q2Q % growth | 0.00 100.00% | -0.03 | 0.03 | 100.00% |
| Q4 2024 Q2Q % growth | -0.02 83.33% | -0.04 | 0.02 | 43.98% |
| Q3 2024 Q2Q % growth | -0.02 88.24% | -0.07 | 0.05 | 71.11% |
| Q2 2024 Q2Q % growth | -0.06 53.85% | -0.07 | 0.01 | 10.60% |
| Q1 2024 Q2Q % growth | -0.06 33.33% | -0.09 | 0.03 | 35.36% |
| Q4 2023 Q2Q % growth | -0.12 7.69% | -0.09 | -0.03 | -26.69% |
| Q3 2023 Q2Q % growth | -0.17 -54.55% | -0.08 | -0.09 | -108.33% |
| Q2 2023 Q2Q % growth | -0.13 31.58% | -0.09 | -0.04 | -47.05% |
| Q1 2023 Q2Q % growth | -0.09 50.00% | -0.11 | 0.02 | 17.92% |
| Q4 2022 Q2Q % growth | -0.13 60.61% | -0.13 | 0.00 | 0.68% |
| Q3 2022 Q2Q % growth | -0.11 68.57% | -0.14 | 0.03 | 22.04% |
| Q2 2022 Q2Q % growth | -0.19 13.64% | -0.14 | -0.05 | -33.05% |
| Q1 2022 Q2Q % growth | -0.18 | -0.18 | 0.00 | -2.60% |
| Q4 2021 Q2Q % growth | -0.33 | -0.22 | -0.11 | -52.85% |
| Q3 2021 Q2Q % growth | -0.35 | -0.24 | -0.11 | -42.97% |
| Q2 2021 Q2Q % growth | -0.22 | -0.14 | -0.08 | -54.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 363.809M 16.34% | 362.72M | 1.089M | 0.30% |
| Q2 2025 Q2Q % growth | 345.311M 10.56% | 352.12M | -6.809M | -1.93% |
| Q1 2025 Q2Q % growth | 332.97M 10.83% | 339.56M | -6.59M | -1.94% |
| Q4 2024 Q2Q % growth | 325.48M 15.99% | 319.99M | 5.49M | 1.72% |
| Q3 2024 Q2Q % growth | 312.722M 18.95% | 308.65M | 4.072M | 1.32% |
| Q2 2024 Q2Q % growth | 312.331M 20.32% | 313.72M | -1.389M | -0.44% |
| Q1 2024 Q2Q % growth | 300.437M 18.94% | 304.97M | -4.533M | -1.49% |
| Q4 2023 Q2Q % growth | 280.603M 22.32% | 268.26M | 12.343M | 4.60% |
| Q3 2023 Q2Q % growth | 262.895M 20.82% | 260.26M | 2.635M | 1.01% |
| Q2 2023 Q2Q % growth | 259.578M 23.90% | 260.26M | -682K | -0.26% |
| Q1 2023 Q2Q % growth | 252.589M 24.37% | 251.35M | 1.239M | 0.49% |
| Q4 2022 Q2Q % growth | 229.4M 20.74% | 220.94M | 8.46M | 3.83% |
| Q3 2022 Q2Q % growth | 217.6M 25.20% | 223.89M | -6.29M | -2.81% |
| Q2 2022 Q2Q % growth | 209.5M 30.53% | 216.47M | -6.97M | -3.22% |
| Q1 2022 Q2Q % growth | 203.1M 41.93% | 203.04M | 60K | 0.03% |
| Q4 2021 Q2Q % growth | 190M 60.88% | 195.53M | -5.53M | -2.83% |
| Q3 2021 Q2Q % growth | 173.8M 70.39% | 174.78M | -980K | -0.56% |
| Q2 2021 Q2Q % growth | 160.5M 91.07% | 158.66M | 1.84M | 1.16% |
| Q1 2021 Q2Q % growth | 143.1M 95.76% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -25% | -25% | -23.51% | 38.46% |
| Revenue | 0.02% | -0.19% | 0.07% | 0.28% |